ImmunologybioRxivPreprint
NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer
B. Salome, J. P. Sfakianos, J. Daza…·Mariath
This study identifies NKG2A and HLA-E as an alternative immune checkpoint axis in bladder cancer, showing NKG2A+ CD8 T cells can bypass HLA-ABC loss through TCR-independent cytotoxicity.
DOI 10.1101/2022.03.04.482960